U
Curanex Pharmaceuticals Inc CURX
$4.02 $0.020.50% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 03/31/2024
Total Cash And Short-Term Investments 33.58% -39.05% 0.00%
Total Receivables -- -- --
Inventory -- -- --
Prepaid Expenses 425.00% -- --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets 33.41% 12.47% --
Total Current Assets 34.41% -9.36% --

Total Current Assets 34.41% -9.36% --
Net Property, Plant & Equipment -- -- --
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -- -- --
Total Assets 51.94% -19.84% --

Total Accounts Payable 2,422.00% -- --
Total Accrued Expenses -59.38% 71.43% --
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -- -- --
Total Finance Division Other Current Liabilities -- -- --
Total Other Current Liabilities -- -- --
Total Current Liabilities 1,219.18% 160.71% --

Total Current Liabilities 1,219.18% 160.71% --
Long-Term Debt -- -- --
Short-term Debt -- -- --
Capital Leases -- -- --
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -- -- --
Total Liabilities 2,784.93% 160.71% --

Common Stock & APIC 0.00% 0.00% --
Retained Earnings -22.11% -28.25% --
Treasury Stock & Other 0.00% 0.00% --
Total Common Equity -27.34% -21.41% 0.00%

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable 0.00% 0.00% --
Preferred Stock Convertible -- -- --
Preferred Stock, Others -- -- --
Total Preferred Equity 0.00% 0.00% --

Total Common Equity -27.34% -21.41% 0.00%
Total Preferred Equity 0.00% 0.00% --
Total Minority Interest -- -- --
Total Equity -27.33% -21.41% 0.00%